✦ LIBER ✦

The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro

✍ Scribed by Tudor Bîrsan; Camille Dambrin; Derrick G. Freitag; Randall W. Yatscoff; Randall E. Morris

Book ID: 113020051
Publisher: Springer
Year: 2005
Tongue: English
Weight: 256 KB
Volume: 17
Category: Article
ISSN: 0934-0874
DOI: 10.1007/s00147-004-0799-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The novel calcineurin inhibitor ISA247:

The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro

✍ Tudor Bîrsan; Camilla Dambrin; Derrick G. Freitag; Randall W. Yatscoff; Randall 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 450 KB

The non-immunosuppressive cyclosporin DE

The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro

✍ Jan Paeshuyse; Artur Kaul; Erik De Clercq; Brigitte Rosenwirth; Jean-Maurice Dum 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

Cyclosporin A (CsA) inhibits the in vitro replication of HCV subgenomic replicons. We here report on the potent anti-HCV activity of the non-immunosuppressive cyclosporin DEBIO-025. The 50% effective concentration for inhibition of HCV subgenomic replicon replication in Huh 5-2 cells (luciferase ass

HIV protease inhibitor ritonavir: a more

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833

✍ Jürgen Drewe; Heike Gutmann; Gert Fricker; Michael Török; Christoph Beglinger; J 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 877 KB

TCT-136: The Novel Synthetic Peptide PSR

TCT-136: The Novel Synthetic Peptide PSRCDCR-NH2 Is A More Potent Inhibitor Than Aspirin And Heparin In An Experimental Carotid Artery Thrombosis Model

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 85 KB

The novel Hsp-90 inhibitor SNX7081 is si

The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway

✍ O. Giles Best; Nisha Singh; Cecily Forsyth; Stephen P. Mulligan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

A novel fragment derived from the β chai

A novel fragment derived from the β chain of human fibrinogen, β43–63, is a potent inhibitor of activated endothelial cells in vitro and in vivo

✍ Krajewska, E; Lewis, C E; Chen, Y-Y; Welford, A; Tazzyman, S; Staton, C A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 608 KB